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INTRODUCTION

HOSPITAL COURSE

• Hydralazine induced ANCA vasculitis (HIAV) is a small vessel
vasculitis that typically presents with multiorgan system
involvement sometimes including severe renal and pulmonary
impairment

• Hydralazine was stopped and added to allergy list

• On literature review, there have only been 4 previously reported
cases of HIAV that were limited to renal involvement1

• Patient’s kidney function improved and was discharged

• Here, we present a

5th

case of HIAV that displayed renal limitation

INITIAL PRESENTATION

• Patient completed pulse dose steroids then transitioned to PO
• Patient completed six sessions of plasmapheresis and four
rituximab infusions
• A kidney biopsy was deferred due to bleeding risk, low platelet
count, platelet dysfunction from aspirin, low fibrinogen levels
due to plasmapheresis, and patient’s religious contraindication
to transfusion

• A 65-year-old male presented to the hospital with fatigue, weight
loss, and shortness of breath for the past three months
Past Medical History:
• HTN, CKD II, CAD, and Microscopic Hematuria
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Figure 2: Kidney function baseline prior to hospitalization compared
to labs during and after hospitalization. Response to treatment was
seen as creatinine returned to near baseline and MPO and PR3
decreased. Of note, the first three PR3 values were >8.0 and the
fourth was exactly 8.0 limiting representation of improvement in PR3
in this case.

Medications:
• Aspirin 81 mg, Carvedilol 25 mg twice a day, and Hydralazine 100
mg three times a day
Social History:
• Jehovah's witness

DISCUSSION
• HIAV presents with constitutional symptoms but may impact many
systems including musculoskeletal, cutaneous, pulmonary, and renal

Physical Exam:
• Vitals: 98.6 F, 126/71 mmHg, 65 beats per minute, 23 respirations
per minute, 97% on room air
• Chronic psoriatic rash over lower extremities
Pertinent Laboratory Findings
Measurement (units)
Result
Normal Range
WBC (K/mcL)
4.0
4.2 - 11.0
HGB (g/dL)
8.4
13.0 - 17.0
BUN (mg/dL)
65
6 - 20
Creatinine (mg/dL)
7.22
0.67 - 1.17
Urinalysis Erythrocytes
>100, few dysmorphic
None Seen, 1 to 2
(cells/hpf)
RBCs
Urinalysis Protein (mg/dL) 30
Negative
Urine Protein/Creatinine 1060
<=199
Ratio (mgPR/gCR) (done 2
days prior to arrival)
Blood Culture x2
No growth for 6 days
No growth
ESR (mm/hr)
101
0-20
CRP (mg/dL)
1.6
<1.0
ANA Titer
Positive, 1:1280
Negative
ANA Pattern
Homogenous
N/a
MPO (AI)
PR3 (AI)
C3 (mg/dL)
C4 (mg/dL)

9
8
7
6
5
4
3
2
1
0
1/3/20

VALUE (MG/DL OR AI)

1Aurora

Positive, >8.0
Positive, >8.0
64
13.9

<1.0
<1.0
79-152
16.0-38.0

• Diagnosis is made primarily by serology which will often show
positive ANA, MPO, PR3, occasional anti dsDNA, low complement
levels, and kidney biopsy showing crescentic glomerulonephritis with
minimal immune complex deposition2
• Treatment includes cessation of hydralazine and initiation of
immunosuppression in severe presentations
• Hydralazine induced lupus is often misdiagnosed but differs by
usually not presenting with severe renal impairment, will be
negative for MPO and PR3, and positive for anti-histone antibody

F
Figure: Images A-E depict immunofluorescence of a kidney biopsy
stained with IgM statin, IgG statin, IgA statin, C3 statin, and C1q
statin respectively. Notice the minimal signal throughout these photos
as there is little immune complex deposition in HIAV.
Image F shows a light microscopy slide from a separate patient
displaying a cellular crescent. Of note, these pictures were not from
our patient. They are just a representation of characteristic findings
for a patient with HIAV.
Images A-E obtained from:
https://pubmed.ncbi.nlm.nih.gov/33993184/
Image F obtained from:
https://www.pathologyoutlines.com/topic/kidneyANCArelatedgngen.ht
ml

• Aggressive immunosuppressive therapy without kidney biopsy was
initiated in our patient due to degree and rate of renal impairment in
the setting of a likely diagnosis

CONCLUSION
• HIAV has a diverse presentation, including a renal limited form, for
which greater awareness will result in proper treatment including
cessation of hydralazine and initiation of immunosuppressive
therapies
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